Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Article | September 30, 2015

Safe Harbor Protects Supplier of Active Ingredient for ANDA

Blog | September 23, 2015

Update on EU Unitary Patent and Unified Patent Court Developments

Blog | September 08, 2015

NDCA allows "real estate" approach (lines of code) for apportionment

Blog | September 04, 2015

NDTX affirms damages verdict; cites most favored licensee clause; limited infringement did not warrant a lower award

Blog | September 02, 2015

Injunction Denied, Sandoz Clear to Launch

Blog | August 27, 2015

BPCIA Dance Partners Request En Banc Rehearing and Amgen Seeks Temporary Injunction

Article | August 12, 2015

Process Patents Are Vital In Biotech — Why Not Extend Them?

Blog | August 10, 2015

FCC Releases Notice of Proposed Rulemaking on Approval Procedures for Radiofrequency Devices

Blog | August 10, 2015

The Second Circuit Avoids the "Registration" Question

Blog | July 29, 2015

Sanofi Challenges Two Members of "Cabilly" Family of Patents

Blog | July 27, 2015

Judicial Review Available for Decision that a Patent Qualified for CBM Review; § 101 Review Appropriate in CBM Review

Blog | July 24, 2015

PTAB's Construction Must Be "Reasonable" In Light of All Intrinsic Evidence, PTAB May Require Patentee to Show Amended Claims Are Patentable Over All Prior Art of Record